German Biotech Startup Tomorrow Bio Pioneers Cryopreservation for Future Revival

BTCC / BTCC Square / Global Cryptocurrency /

Author:

Release Time:

2025-05-16 06:29:01

Tomorrow Bio, a German biotech startup, is turning science fiction into reality with its cryopreservation services. The company aims to preserve human bodies at ultra-low temperatures post-death, banking on future medical advancements to enable revival. The process involves cooling the body to -198°C, inducing a state of biostasis where all biological activity ceases.

The concept of cryopreservation has long been a staple of speculative fiction, but Tomorrow Bio is grounding it in scientific rigor. By halting decay at the molecular level, the startup offers a glimmer of hope for those betting on tomorrow’s breakthroughs to conquer mortality.

By:

Log in to Reply

Polymarket Sees Record Market Creation Amid Declining Trader Activity

Articles on this site are sourced from public networks or curated by AI for informational purposes only and do not represent BTCC’s views. Original rights belong to the respective authors. For copyright concerns, please contact [email protected]. BTCC assumes no liability for the accuracy, timeliness, or completeness of this information, and disclaims all liability arising from reliance on such content. This content is for reference only and should not be taken as investment, legal, or commercial advice.